Second medical use
Novartis and Freshfields win PIs against eight generics companies in fingolimod battle
In one of Europe's biggest pharmaceutical disputes, Novartis has won an important victory against the generic drug industry over MS drug fingolimod. By means of a preliminary injunction, the Düsseldor
...
31 January 2023 by Mathieu Klos